A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
Clinical trial NCT03273153 · TERMINATED
Trial details
- NCT number
- NCT03273153
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-11
- Primary completion
- 2019-04-15
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.